Alvotech (ALVOW) Non-Current Debt (2020 - 2025)
Alvotech (ALVOW) reported Non-Current Debt of $1.3 billion for Q4 2025, up 21.84% on a YoY basis from $1.0 billion in Q4 2024, and up 16.69% quarter-over-quarter from $1.1 billion in Q3 2025.
Alvotech (ALVOW) Non-Current Debt (2020 - 2025) Analysis & Trends
Alvotech has reported Non-Current Debt for 6 years, with the latest figure at $1.3 billion in Q4 2025.
- For the quarter ending Q4 2025, Non-Current Debt rose 21.84% year-over-year to $1.3 billion; the trailing twelve-month figure through Dec 2025 stood at $1.3 billion (up 21.84% YoY), and the FY2025 full-year result was $1.3 billion, up 21.84% from the prior year.
- Non-Current Debt for Q4 2025 stood at $1.3 billion, up from $1.1 billion in the prior quarter.
- The five-year high for Non-Current Debt was $1.3 billion in Q4 2025, with the low at $56.9 million in Q2 2024.
- Historically, Non-Current Debt has averaged $827.1 million across 5 years, with a median of $931.4 million in 2023.
- Annual changes were most pronounced in 2024 — Non-Current Debt slumped 92.77% — and 2025, when it jumped 1785.01%.
- Alvotech's Non-Current Debt stood at $398.1 million in 2021, then soared by 87.03% to $744.7 million in 2022, then rose by 23.83% to $922.1 million in 2023, then rose by 12.34% to $1.0 billion in 2024, then climbed by 21.84% to $1.3 billion in 2025.
- The last three Non-Current Debt figures came in at $1.3 billion (Q4 2025), $1.1 billion (Q3 2025), and $1.1 billion (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 14.02 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 9.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 3.92 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.48 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 569.60 Mn |
| 10 | Alvotech | - | - | -22.39 Mn | 1.26 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.26 Bn |
| Dec 31, 2025 | 1.26 Bn |
| Sep 30, 2025 | 1.08 Bn |
| Sep 30, 2025 | 1.08 Bn |
| Jun 30, 2025 | 1.07 Bn |
| Jun 30, 2025 | 1.07 Bn |
| Mar 31, 2025 | 1.06 Bn |
| Mar 31, 2025 | 1.06 Bn |
| Dec 31, 2024 | 1.04 Bn |
| Dec 31, 2024 | 1.04 Bn |
| Sep 30, 2024 | 1.01 Bn |
| Sep 30, 2024 | 1.01 Bn |
| Jun 30, 2024 | 56.88 Mn |
| Jun 30, 2024 | 56.88 Mn |
| Mar 31, 2024 | 940.59 Mn |
| Mar 31, 2024 | 940.59 Mn |
| Dec 31, 2023 | 922.13 Mn |
| Dec 31, 2023 | 922.13 Mn |
| Jun 30, 2023 | 786.18 Mn |
| Jun 30, 2023 | 786.18 Mn |